Net revenue for the period also went down from CA$23.2 million to CA$14.6 million.
The Organigram Analyst
Cantor Fitzgerald’s Pablo Zuanic maintained an Overweight rating on Organigram and raised the price target from CA$6 to CA$6.15.
The Organigram Takeaways
The cannabis company's second-quarter results were worse than projected, with the COVID-19 pandemic affecting sales trends at the point of sale and adult-use sales being affected by capacity constraints Zuanic said in a Wednesday note.